Fly News Breaks for November 18, 2019
Nov 18, 2019 | 05:33 EDT
Piper Jaffray analyst Matt O'Brien took over coverage of DexCom and reiterates an Overweight rating on the shares with a price target of $230, up from $200. The company has seen an inflection in growth driven by its product that does not require the patient to finger stick anymore, says the analyst.
News For DXCM From the Last 2 Days